Update on Epstein-Barr virus and gastric cancer (review).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Oncology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2015.2856PMID 25633561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.

  2015cited by this paper
• Case–case comparison of smoking and alcohol risk associations with Epstein–Barr virus‐positive gastric cancer

  2014cited by this paper
• MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1

  2014cited by this paper
• The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma

  2014cited by this paper
• DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus.

  2014cited by this paper
• Immune modulation for cancer therapy

  2014cited by this paper
• Epstein-Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection: case series.

  2014cited by this paper
• Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.

  2014cited by this paper
• Epstein–Barr virus maintains lymphomas via its miRNAs

  2014cited by this paper
• Epstein-Barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by Notch signaling pathway.

  2014cited by this paper
• EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells

  2014cited by this paper
• Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments.

  2014cited by this paper
• CpG Island Methylator Phenotype, Helicobacter pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Co-infections, inflammation and oncogenesis: future directions for EBV research.

  2014cited by this paper
• Comprehensive molecular characterization of gastric adenocarcinoma

  2014cited by this paper
• PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy.

  2014cited by this paper
• The Epstein-Barr Virus-Encoded MicroRNA MiR-BART9 Promotes Tumor Metastasis by Targeting E-Cadherin in Nasopharyngeal Carcinoma

  2014cited by this paper
• The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.

  2013cited by this paper
• Role of DNA methylation in the development of Epstein–Barr virus‐associated gastric carcinoma

  2013cited by this paper
• BamHI-A rightward frame 1, an Epstein–Barr virus-encoded oncogene and immune modulator

  2013cited by this paper
• Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration.

  2013cited by this paper
• Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.

  2013cited by this paper
• Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy

  2013cited by this paper
• Emerging Roles of Small Epstein-Barr Virus Derived Non-Coding RNAs in Epithelial Malignancy

  2013cited by this paper
• Epstein-Barr Virus-Encoded MicroRNA BART15-3p Promotes Cell Apoptosis Partially by Targeting BRUCE

  2013cited by this paper
• Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.

  2013cited by this paper
• Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis

  2013cited by this paper
• PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

  2013cited by this paper
• Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport

  2013cited by this paper
• Epstein-Barr Virus-Encoded BARF1 Promotes Proliferation of Gastric Carcinoma Cells through Regulation of NF-κB

  2013cited by this paper
• Identification of genes specifically methylated in Epstein–Barr virus‐associated gastric carcinomas

  2013cited by this paper
• Expression Profile of MicroRNAs in Epstein-Barr Virus-Infected AGS Gastric Carcinoma Cells

  2013cited by this paper
• Genome‐wide identification of Epstein‐Barr virus–driven promoter methylation profiles of human genes in gastric cancer cells

  2013cited by this paper
• Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

  2012cited by this paper
• Biogenesis of Epstein–Barr virus microRNAs

  2012cited by this paper
• High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

  2012cited by this paper
• Epstein-Barr virus infection as an epigenetic driver of tumorigenesis.

  2012cited by this paper
• MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing

  2012cited by this paper
• Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma.

  2012cited by this paper
• The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines

  2012cited by this paper
• EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas

  2012cited by this paper
• Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile

  2012cited by this paper
• ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability

  2012cited by this paper
• Clinical significance of gastritis cystica profunda and its association with Epstein‐Barr virus in gastric cancer

  2012cited by this paper
• Infection of Epstein–Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression

  2012cited by this paper
• The biology of EBV infection in human epithelial cells.

  2012cited by this paper
• EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latency

  2012cited by this paper
• Epstein-Barr Virus-associated Gastric Carcinoma: A Newly Defined Entity

  2012cited by this paper
• Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.

  2012cited by this paper
• Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

  2012cited by this paper
• Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs

  2012cited by this paper
• This information is current as Production β Inflammasome and IL-1 miR-BART 15 Regulate the NLRP 3 Cutting Edge : miR-223 and EBV

  2012cited by this paper
• The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.

  2011cited by this paper
• Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A

  2011cited by this paper
• Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma

  2011cited by this paper
• Pathology of Epstein-Barr Virus-Associated Gastric Carcinoma and Its Relationship to Prognosis

  2011cited by this paper
• Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis

  2011cited by this paper
• Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.

  2011cited by this paper
• Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

  2011cited by this paper
• A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia

  2011cited by this paper
• Epstein-Barr Virus BART9 miRNA Modulates LMP1 Levels and Affects Growth Rate of Nasal NK T Cell Lymphomas

  2011cited by this paper
• Epstein-Barr virus-associated gastric carcinoma.

  2011cited by this paper
• EBV-encoded miRNAs.

  2011cited by this paper
• Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.

  2011cited by this paper
• Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.

  2011cited by this paper
• Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells

  2010cited by this paper
• microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma

  2010cited by this paper
• Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay.

  2010cited by this paper
• Gastric carcinoma with osteoclast‐like giant cells. Lymphoepithelioma‐like carcinoma with Epstein–Barr virus infection is the predominant type

  2010cited by this paper
• Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency*

  2010cited by this paper
• Prominent Mott cell proliferation in Epstein-Barr virus-associated gastric carcinoma.

  2010cited by this paper
• Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.

  2010cited by this paper
• Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing

  2010cited by this paper
• Downregulation of microRNA-200 in EBV-associated gastric carcinoma.

  2010cited by this paper
• Role of EBERs in the pathogenesis of EBV infection.

  2010cited by this paper
• Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

  2009cited by this paper
• Clinicopathological and molecular characteristics of Epstein–Barr virus‐associated gastric carcinoma: A meta‐analysis

  2009cited by this paper
• Characteristics of Epstein-Barr virus-associated gastric cancer: A study of 235 cases at a comprehensive cancer center in U.S.A

  2009cited by this paper
• The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species

  2009cited by this paper
• Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.

  2009cited by this paper
• Epstein-Barr virus BART gene expression.

  2009cited by this paper
• Epstein-Barr Virus-associated Gastric Carcinoma: A Distinct Carcinoma of Gastric Phenotype by Claudin Expression Profiling

  2009cited by this paper
• Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.

  2009cited by this paper
• Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification

  2009cited by this paper
• Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas

  2009cited by this paper
• Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.

  2009cited by this paper
• Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells

  2008cited by this paper
• Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma

  2008cited by this paper
• An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival

  2008cited by this paper
• Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer

  2008cited by this paper
• EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

  2008cited by this paper
• Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.

  2008cited by this paper
• Modulation of LMP1 protein expression by EBV-encoded microRNAs

  2007cited by this paper
• Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5

  2007cited by this paper
• Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma

  2006cited by this paper
• siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.

  2006cited by this paper
• Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus

  2006cited by this paper
• Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node Metastases

  2006cited by this paper
• Anti-apoptotic role of BARF1 in gastric cancer cells.

  2006cited by this paper
• Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.

  2005cited by this paper

• Epstein-Barr Virus Associated Gastric Carcinoma: A Clinicopathologic Study with Recognition of a Distinctive Reticular Histologic Pattern.

  2026cites this paper
• Demographic/clinicopathological characteristics and prognosis of resectable Epstein-Barr virus-associated gastric cancer: a nested case-control study from an Eastern China

  2026cites this paper
• Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives

  2025cites this paper
• Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital

  2025cites this paper
• Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome

  2025cites this paper
• Proportional Correlation Between Systemic Inflammation Response Index and Gastric Cancer Recurrence Time: A Retrospective Study

  2025cites this paper
• A robust artificial intelligence system for predicting EBV status in gastric cancer biopsy and resection specimens

  2025cites this paper
• DNA‐hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation

  2025influential citation
• Epstein-Barr virus modulates iron metabolism and ferritin expression to promote tumorigenesis in gastric cancer

  2025cites this paper
• Evolutionary interplay between viruses and R‐loops

  2025cites this paper
• Epstein-Barr virus-coded miR-BART19-3p promotes proliferation of EBV-associated gastric cancer by inhibiting GADD45B

  2025cites this paper
• Microorganisms in Cancer Tertiary Lymphoid Structure Formation.

  2025cites this paper
• Gastric Carcinoma.

  2025cites this paper
• Epstein-Barr virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review.

  2025cites this paper
• A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

  2025cites this paper
• Global Epidemiology of PD-L1 Expression in Epstein-Barr Virus-Associated Gastric Cancer: A Systematic Review and Meta-Analysis

  2025cites this paper
• Research Progress on the Tumor Microenvironment and Immunotherapy of Gastric Cancer

  2025cites this paper
• DriverSub-SVM: a machine learning approach for cancer subtype classification by integrating patient-specific and global driver genes

  2025cites this paper
• The use of peptides for deciphering the mechanism of EBV, HPV, and HCV invasion of human cells

  2025cites this paper
• Viral oncogenesis in cancer: from mechanisms to therapeutics

  2025cites this paper
• Environmental factors in gastric carcinogenesis and preventive intervention strategies

  2025cites this paper
• Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects

  2025cites this paper
• Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications

  2025cites this paper
• Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma

  2024cites this paper
• Recognizing the role of Epstein-Barr virus in gastric cancer: transcriptomic insights into malignancy modulation

  2024cites this paper
• Viruses in glioblastoma: an update on evidence and clinical trials

  2024cites this paper
• Common variants of vitamin D receptor gene polymorphisms and risk of gastric cancer: A meta-analysis

  2024cites this paper
• Association of PD-L1 positivity with Epstein Barr virus infection and microsatellite instability in gastric carcinomas with lymphoid stroma

  2024cites this paper
• Histone methylation in Epstein-Barr virus-associated diseases.

  2024cites this paper
• Effect of Epstein-Barr Virus Infection on the Treatment of Gastric Cancer in Tumor Immunotherapy

  2024cites this paper
• Research advances in the molecular classification of gastric cancer

  2024cites this paper
• Prognostic Effect of Tertiary Lymphoid Structures in Epstein-Barr Virus-associated Gastric Carcinomas measured by Digital Image Analysis.

  2024cites this paper
• The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape

  2024influential citation
• The Trends of Gastric Cancer in China From 1990 to 2019 and Predictions to 2040: A Bayesian Age-Period-Cohort Prediction Study

  2024cites this paper
• Differential cytokine expression in gastric tissues highlights helicobacter pylori’s role in gastritis

  2024cites this paper
• Research landmarks on the 60th anniversary of Epstein-Barr virus

  2024cites this paper
• Research Progress of EB Virus-Associated Gastric Cancer

  2024cites this paper
• Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues

  2024cites this paper
• FTO up‐regulation induced by MYC suppresses tumour progression in Epstein‒Barr virus‐associated gastric cancer

  2023cites this paper
• Pathogenesis and therapeutic implications of EBV-associated epithelial cancers

  2023influential citation
• Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy

  2023cites this paper
• Bleomycin alters intratumoral immune response of EBV-associated gastric cancer by ENTPD8 and PCOLCE2

  2023cites this paper
• The prevalence of varicella zoster virus, herpes simplex virus type 2, and human papillomavirus in breast cancerous tissues and their adjacent ones in Iran

  2023cites this paper
• Current management of gastric adenocarcinoma: a narrative review

  2023cites this paper
• Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

  2023cites this paper
• Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis

  2023cites this paper
• Oncoviruses: How do they hijack their host and current treatment regimes.

  2023cites this paper
• The Human Gastric Juice: A Promising Source for Gastric Cancer Biomarkers

  2023cites this paper
• Oncogenic viruses and host lipid metabolism: a new perspective.

  2023cites this paper
• Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis

  2023cites this paper
• Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus‐associated gastric carcinoma

  2023cites this paper
• The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis

  2023cites this paper
• Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer

  2023cites this paper
• Quantitative analysis of Epstein–Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer

  2023cites this paper
• MiR-BART1-3p and BART18-5p inhibit cell migration, proliferation and activate autophagy in Epstein-Barr virus-associated gastric cancer by targeting erythropoietin-producing human hepatocellular 2

  2023cites this paper
• A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers

  2023cites this paper
• Is There an Association between Concurrent Epstein–Barr Virus Infection and Sudden Hearing Loss?—A Case—Control Study in an East Asian Population

  2023cites this paper
• Map of thrombogenesis in viral infections and viral-driven tumours

  2023cites this paper
• A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment

  2023cites this paper
• Gastric immune homeostasis imbalance: An important factor in the development of gastric mucosal diseases.

  2023cites this paper
• The role of LMP1 in Epstein-Barr virus-associated gastric cancer.

  2023cites this paper
• Assessing Epstein–Barr virus in gastric cancer: clinicopathological features and prognostic implications

  2023cites this paper
• Molecular mechanism of aquaporin 3 (AQP3) regulating by LMP2A and its crosstalk with 4E-BP1 via ERK signaling pathway in EBV-associated gastric cancer.

  2022cites this paper
• Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity

  2022cites this paper
• Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles.

  2022cites this paper
• Clinical and pathologic characteristics of gastric adenocarcinoma associated with Epstein-Barr virus in a region with a high incidence of gastric cancer in Colombia.

  2022cites this paper
• Clinicopathological Characteristics of Advanced Epstein–Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression

  2022cites this paper
• Epstein–Barr virus and multiple sclerosis

  2022cites this paper
• LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma.

  2022cites this paper
• Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration

  2022cites this paper
• Características clínico-patológicas del adenocarcinoma gástrico asociado al virus de Epstein-Barr en una región de alta incidencia de cáncer gástrico en Colombia

  2022cites this paper
• Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism

  2022cites this paper
• PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis

  2022cites this paper
• [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs].

  2022cites this paper
• LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis

  2022cites this paper
• Viral and Clinical Oncology of Head and Neck Cancers

  2022cites this paper
• Helicobacter Pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – a Pilot Study

  2022cites this paper
• Epstein-barr virus/Helicobacter pylori coinfection and gastric cancer: the possible role of viral gene expression and shp1 methylation

  2022cites this paper
• Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer

  2022cites this paper
• Establishment and characterization of two Epstein–Barr virus‐positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles

  2022cites this paper
• A Network Pharmacology Perspective Investigation of the Pharmacological Mechanisms of the Herbal Drug FDY003 in Gastric Cancer

  2022cites this paper
• Detection of Epstein Barr Virus DNA in Gastric Adenocarcinoma in Brazzaville

  2022cites this paper
• DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer

  2022cites this paper
• Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments

  2022cites this paper
• Epstein‐Barr virus miR‐BART2‐5p and miR‐BART11‐5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma

  2022influential citation
• EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative

  2022cites this paper
• Prediction of Epstein-Barr Virus Status in Gastric Cancer Biopsy Specimens Using a Deep Learning Algorithm

  2022cites this paper
• Inflammation and Gastric Cancer

  2022cites this paper
• Lymphoepithelioma-like cholangiocarcinoma not associated with Epstein–Barr virus or hepatitis virus: case report and literature review of 100 reported cases

  2022cites this paper
• Analysis of the relationship between the expression of EBV-related antibodies and ET-1 axis in gastric cancer.

  2022cites this paper
• An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer

  2022cites this paper
• PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer

  2022cites this paper
• Serologically positive gastric cancers associated with Epstein-Barr virus

  2021cites this paper
• Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis.

  2021cites this paper
• Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies

  2021cites this paper
• Epstein-Barr Virus-Associated Gastric Cancer: Old Entity with New Relevance

  2021cites this paper
• Prevalence of HSV, Varicella-Zoster, CMV, EBV and HPV in the oral cavity and the larynx carcinoma in Iran

  2021cites this paper
• A case of Epstein Barr virus-associated primary squamous cell carcinoma of stomach

  2021cites this paper
• Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

  2021cites this paper
• Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?

  2021cites this paper